Archives
-
D-Luciferin and the Next Era of Pain Imaging
2026-08-09
D-Luciferin potassium salt is more than a routine luciferase reagent: it can help translational teams separate tumor burden, pathway activity, and symptom biology in longitudinal preclinical studies. This article connects firefly luciferase chemistry with emerging evidence on CXCL1-CXCR2-driven microglial activation in pancreatic cancer pain, while defining practical workflow limits and opportunities.
-
Dual-Mode mRNA Tracking for Translational Delivery
2026-08-08
A mechanistic and strategic framework for using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) to distinguish delivery, intracellular trafficking, and productive translation while evaluating next-generation extrahepatic mRNA platforms.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-07
Pair Cy5 fluorescence for delivery and trafficking with firefly luciferase for productive translation in one reporter transcript. This workflow shows how to optimize mRNA delivery and transfection, compare delivery platforms, and interpret uptake-expression mismatches without confusing particle association with functional protein production.
-
Engineered Klotho mRNA Delivery Rejuvenates Senescent iMSCs
2026-07-30
This study demonstrates that hyperbranched poly(β-amino ester)s (HPAEs) enable efficient delivery of engineered Klotho mRNA to reverse cellular senescence and restore homeostasis in aged or Klotho-deficient induced mesenchymal stem cells (iMSCs). The findings highlight the therapeutic promise of mRNA engineering and advanced delivery systems for regenerative medicine and anti-aging strategies.
-
Multidimensional Ionizable Lipid Design for Organ-Selective
2026-07-29
This study introduces a systematic approach to generate diverse ionizable lipid (IL) libraries for lipid nanoparticle (LNP)-mediated mRNA delivery using the Ugi four-component reaction. The findings reveal how IL isomerism and skeleton tuning enable robust, organ-specific mRNA transfection, advancing the rational design of LNPs for mRNA therapeutics.
-
D-Luciferin Potassium Salt: Optimizing Bioluminescence Imagi
2026-07-29
D-Luciferin (potassium salt) transforms in vivo and in vitro luciferase assays by improving water solubility, workflow simplicity, and signal precision. Explore protocol enhancements, troubleshooting strategies, and the latest innovations that make this APExBIO substrate the gold standard for sensitive, reproducible bioluminescence imaging.
-
LNP-Delivered NGFR100W mRNA: A Therapeutic Avenue for Neurop
2026-07-28
This study demonstrates that lipid nanoparticle (LNP) delivery of chemically modified NGFR100W mRNA enables robust, safe, and functional protein expression, alleviating chemotherapy-induced peripheral neuropathy in mouse models. The findings highlight both the therapeutic promise of in vitro transcribed, immune-evasive mRNAs and the utility of rational mRNA engineering in overcoming the limitations of native protein supplementation.
-
Engineered Klotho mRNA Delivery Reverses Senescence in iMSCs
2026-07-27
This study demonstrates that hyperbranched poly(β-amino ester)s (HPAEs) enable efficient delivery of engineered Klotho mRNA, reversing senescence and restoring homeostasis in aged and Klotho-deficient induced mesenchymal stem cells (iMSCs). The findings highlight the therapeutic potential of modified mRNA platforms for combating age-associated cellular dysfunction and advancing regenerative medicine strategies.
-
D-Luciferin Sodium Salt: Precision Firefly Luciferase Substr
2026-07-24
D-Luciferin sodium salt is a validated firefly luciferase substrate enabling quantitative, ATP-dependent bioluminescence assays in living cells. Its high solubility and rapid signal kinetics support sensitive cell viability and metabolism monitoring. APExBIO’s B8311 grade substrate is widely adopted for in vivo and cell-based imaging applications.
-
D-Luciferin Sodium Salt: Transforming In Vivo Bioluminescenc
2026-07-23
Discover how D-Luciferin sodium salt revolutionizes in vivo bioluminescence imaging as a firefly luciferase substrate. This article offers a deeper, practical perspective on assay optimization and translational oncology research, grounded in recent advances.
-
mRNA Encapsulation in MOFs: Breakthroughs in Non-Viral Deliv
2026-07-16
This study establishes a new synthetic strategy for encapsulating and delivering messenger RNA (mRNA) using nanoscale metal-organic frameworks (MOFs), specifically ZIF-8. By introducing a polymer-stabilized core-shell system, the researchers demonstrate robust mRNA protection, efficient cellular delivery, and preserved protein expression after long-term room-temperature storage, marking a major advance in non-viral gene delivery platforms.
-
EZ Cap™ Firefly Luciferase mRNA: Advanced Assays & Protocols
2026-07-14
EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables next-generation sensitivity and reproducibility in translation efficiency and gene regulation assays. Integrating the latest in mRNA engineering and delivery science, this guide reveals data-driven workflows, troubleshooting strategies, and cross-validated experimental enhancements.
-
Redefining mRNA Reporter Assays: Mechanism, Delivery, and Im
2026-07-09
This thought-leadership article explores how advanced Firefly Luciferase mRNA reagents—specifically, EZ Cap™ Firefly Luciferase mRNA (5-moUTP)—transform translational workflows. By integrating molecular innovations in mRNA stability and immune evasion with strategic insights from recent lipid nanoparticle delivery research, we provide a roadmap for researchers aiming to achieve reliable and organ-selective gene expression studies.
-
Firefly Luciferase mRNA: Applied Workflows & Troubleshooting
2026-07-09
Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO empowers next-generation bioluminescent assays with robust immune evasion and unmatched stability. Discover practical protocols, advanced delivery strategies, and troubleshooting tactics that translate molecular innovation into reproducible results across gene expression, cell viability, and in vivo imaging applications.
-
Firefly Luciferase mRNA: Applied Workflows & 5-moUTP Power
2026-07-08
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers unmatched stability and translational efficiency for bioluminescent reporter assays. Its advanced 5-moUTP modification and Cap 1 capping enable robust, low-immunogenicity gene expression across mRNA delivery platforms.